Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance

Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance

Background: Evolocumab is a humanized immunoglobulin G2 monoclonal antibody, directed against Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9), prescribed in hypercholesterolemic patients. The safety profile of this drug is currently defined by the data of pre-authorization clinical trials. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabrizio Calapai (Author), Carmen Mannucci (Author), Mariaconcetta Currò (Author), Luigi Cardia (Author), Emanuela Esposito (Author), Gioacchino Calapai (Author), Ilaria Ammendolia (Author)
Format: Book
Published: MDPI AG, 2024-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items